Durata Therapeutics Buy Hold or Sell Recommendation

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Durata Therapeutics is 'Not Rated'. Macroaxis provides Durata Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DRTX positions. The advice algorithm takes into account all of Durata Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Durata Therapeutics' buy or sell advice are summarized below:
Real Value
0.0
Hype Value
0.0
Market Value
0.0
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Durata Therapeutics given historical horizon and risk tolerance towards Durata Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Durata Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
In addition, we conduct extensive research on individual companies such as Durata and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Durata Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Execute Durata Therapeutics Buy or Sell Advice

The Durata recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Durata Therapeutics. Macroaxis does not own or have any residual interests in Durata Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Durata Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice

We are unable to locate Durata Therapeutics Advice at this time.

If you believe the indicator you are trying to look up is valid, please let us know, and we will check it out. Check all delisted instruments across multiple markets.
Symbol  DRTX
Name  Durata Therapeutics
TypeStock
Country  
 United States
Exchange  NASDAQ

Other Suggestions

DR Darwin Professional UnderwritersCompany
DRD DRDGOLD Ltd ADRCompany
DRH-PA DiamondRock HospitalityCompany
DRCVX Comstock Capital ValueMutual Fund
DRN Direxion Daily RealETF
DRG ARCA PharmaceuticalIndex
DRGN DRGNCryptocurrency
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
MSFTMicrosoft
GOOGAlphabet Class C
SSentinelOne
VVisa Class A
CCitigroup

Use Investing Ideas to Build Portfolios

In addition to having Durata Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run SRI Sustainable Growth Thematic Idea Now

SRI Sustainable Growth
SRI Sustainable Growth Theme
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Durata Stock

If you are still planning to invest in Durata Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Durata Therapeutics' history and understand the potential risks before investing.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope